In recent months, some have pointed to cannabis as a possible treatment for severe cases of the Covid-19 – pointing specifically towards the cannabinoid CBD. Now, a synthetic cannabinoid drug, ARDS-003, has been given approval by the FDA to begin phase-1 clinical trials.
Synthetic Cannabinoid Drug For Covid-19 Approved For Phase-1 Clinical Trials
